Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)
China
· Delayed Price · Currency is CNY 190.56
-1.94 (-1.01%)
Jan 3, 2025, 4:00 PM CST
Sichuan Biokin Pharmaceutical Co.,Ltd. Market Cap
Sichuan Biokin Pharmaceutical Co.,Ltd. has a market cap or net worth of 77.41 billion as of January 6, 2025. Its market cap has increased by 65.72% in one year.
Market Cap
77.41B
Enterprise Value
73.98B
Revenue
5.85B
Ranking
n/a
PE Ratio
20.27
Stock Price
190.56
Market Cap Chart
Since January 6, 2023, Sichuan Biokin Pharmaceutical Co.,Ltd.'s market cap has increased from 12.85B to 77.41B, an increase of 502.28%. That is a compound annual growth rate of 146.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 76.41B | -0.61% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 294.68B |
| Jiangsu Hengrui Medicine | 282.07B |
| WuXi AppTec | 150.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.98B |
| Aier Eye Hospital Group | 116.12B |
| Shanghai United Imaging Healthcare | 103.88B |
| Yunnan Baiyao Group Co.,Ltd | 103.36B |
| Beijing Wantai Biological Pharmacy Enterprise | 89.42B |